Skip to main content

Comparison of saliva and oro-nasopharyngeal swab sample in the molecular diagnosis of COVID-19.

Güçlü E, Koroglu M, Yürümez Y, Toptan H, Kose E, Güneysu F, Karabay O

Publication: Rev Assoc Med Bras (1992) (2020) • Vol 66 • Page 1116-1121PMID: 32935807View on PubMed

Purpose

This paper compared detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in matched self-collected saliva specimens with healthcare worker–collected oronasopharyngeal swab specimens.

Conclusion

SARS-CoV-2 RNA was detected in 42.2% of patients and was found in both the saliva and oronasopharyngeal swab specimens in 35.9% of patients, in only the saliva in 6.25% of the patients, and in only the oronasopharyngeal swab specimen for 6.25% of the patients. The diagnostic concordance between the two specimen types was high (κ= 0.744) and was statistically significant.

Studies (1)

Purpose

This study compared detection of SARS-CoV-2 in matched self-collected saliva specimens with healthcare worker–collected oronasopharyngeal swab specimens. Swab specimens were collected by healthcare-workers (details not provided) from 64 patients (42.2% female, 57.8% male) with symptoms suggestive of SARS-CoV-2 infection (fever, cough, and shortness of breath). A single dacron-flocked swab was inserted into the posterior oropharynx, swabbed for 2–3 seconds, then inserted through the nostril until the nasopharynx was reached, rotated gently for 2-3 seconds, and then placed into a tube containing viral transport medium. The patients then collected a saliva specimen into a sterile dry container. All specimens were transported to the laboratory within 1 h. RNA was immediately extracted using a Qiagen EZ1 device and SARS-CoV-2 RNA was detected by real-time RT-PCR.

Summary of Findings

SARS-CoV-2 RNA was detected in 27/64 (42.2%) patients and was found in both the saliva and oronasopharyngeal swab specimens for 23/64 (35.9%) patients, in only the saliva for four (6.25%) patients, and in only the oronasopharyngeal swab specimen for four (6.25%) patients. The diagnostic concordance between the two specimen types was high (κ= 0.744) and was statistically significant (P<0.001).

  • Biospecimens

    FluidSaliva
    CellOral Cavity
    CellNasopharynx
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Pneumonia/Respiratory Infection
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Oronasopharynx
    Saliva
    Biospecimen AcquisitionMethod of cell acquisition
    Healthcare-worker collected swab
    Self-collected saliva
    Real-time qRT-PCR SpecificTargeted nucleic acid
    SARS-CoV-2